期刊
HUMAN MUTATION
卷 40, 期 6, 页码 765-787出版社
WILEY
DOI: 10.1002/humu.23735
关键词
CACNA1F; gene defect; icCSNB; intronic variants; IRD; minigene approach; synonymous variants
资金
- Fondation Voir et Entendre
- Prix Dalloz for La recherche en ophtalmologie
- Ville de Paris
- Region Ile de France
- LABEX LIFESENSES - French state funds [ANR-11-IDEX-0004-0, ANR-10-LABX-65]
- Agence Nationale de la Recherche [ANR-12-BSVS1-0012-01_GPR179]
- Laboratory of Excellence GENMED (Medical Genomics) [ANR-10-LABX0013]
- Health Program of the European Union [739534]
Inherited retinal disorders (IRD) represent clinically and genetically heterogeneous diseases. To date, pathogenic variants have been identified in similar to 260 genes. Albeit that many genes are implicated in IRD, for 30-50% of the cases, the gene defect is unknown. These cases may be explained by novel gene defects, by overlooked structural variants, by variants in intronic, promoter or more distant regulatory regions, and represent synonymous variants of known genes contributing to the dysfunction of the respective proteins. Patients with one subgroup of IRD, namely incomplete congenital stationary night blindness (icCSNB), show a very specific phenotype. The major cause of this condition is the presence of a hemizygous pathogenic variant in CACNA1F. A comprehensive study applying direct Sanger sequencing of the gene-coding regions, exome and genome sequencing applied to a large cohort of patients with a clinical diagnosis of icCSNB revealed indeed that seven of the 189 CACNA1F-related cases have intronic and synonymous disease-causing variants leading to missplicing as validated by minigene approaches. These findings highlight that gene-locus sequencing may be a very efficient method in detecting disease-causing variants in clinically well-characterized patients with a diagnosis of IRD, like icCSNB.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据